Navigation Links
Rosetta Genomics to Present at Rodman & Renshaw 10th Annual Healthcare Conference
Date:11/5/2008

REHOVOT, Israel and JERSEY CITY, New Jersey, November 5 /PRNewswire-FirstCall/ -- Rosetta Genomics Ltd. (Nasdaq:ROSG), a leader in the development of microRNA-based diagnostics, announced today it will present at the Rodman & Renshaw 10th Annual Healthcare Conference on Wednesday, November 10 at The New York Palace Hotel in New York City.

About MicroRNA

MicroRNAs (miRNAs) are recently discovered, naturally occurring, small RNAs that act as master regulators and have the potential to form the basis for a new class of diagnostics and therapeutics. Since many diseases are caused by the abnormal activity of proteins, the ability to selectively regulate protein activity through microRNAs could provide the means to treat a wide range of human diseases. In addition, microRNAs have been shown to have different expression in various pathological conditions. As a result, these differences may provide for a novel diagnostic strategy for many diseases.

About Rosetta Genomics

Rosetta Genomics (Nasdaq: ROSG) is a leader in the field of microRNA. Founded in 2000, the company's integrative research platform combining bioinformatics and state-of-the-art laboratory processes has led to the discovery of hundreds of biologically validated novel human microRNAs. Building on its strong IP position and proprietary platform technologies, Rosetta Genomics is working on the application of these technologies in the development of a full range of microRNA-based diagnostic and therapeutic tools, focusing primarily on c
'/>"/>

SOURCE Rosetta Genomics Ltd
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Rosetta Genomics to Webcast Panel Presentation at RBC Capital Markets 2007 Healthcare Conference
2. Rosetta Genomics Strengthens Senior Management in Preparation for its First Commercial Launch of microRNA-Based Diagnostic Products in 2008
3. NeoGenomics Schedules Its Q3 2008 Earnings Release for November 6, 2008
4. UC San Diego to lead nationwide program in pharmacogenomics
5. NeoGenomics to Present at the Noble Financial Equity Conference
6. NeoGenomics Announces Results for the Second Quarter of Fiscal Year 2008
7. AutoGenomics, Inc. Files Registration Statement for Initial Public Offering
8. AutoGenomics INFINITI Analyzer Receives Artistic Design Award
9. AutoGenomics Receives a Key European Patent for HPV Detection
10. Genomics of Cardiovascular Disease: Current Clinical Applications
11. Navigenics Proposes Standards for Personal Genomics Services, Coupled With Prospective Outcomes Studies, to Safeguard Consumers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... ... June 30, 2015 , ... ... Northwest ENT and Allergy Center . , Dr. Antunes is ... reconstructive, sinus and ear procedures. In addition to performing cosmetic and reconstructive surgery ...
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... ... Surgery, Chief of Orthopaedic Oncology & Sarcoma surgery at HackensackUMC and Director of ... to announce the implementation and distribution of his online Orthopedic Oncology and Pathology ...
(Date:6/30/2015)... ... June 30, 2015 , ... Micro Com Systems has ... quality record management services for patient records. Medical imaging includes services such as ... and clinics. , With the increase in the acceptance level of electronic ...
(Date:6/30/2015)... Miami, FL (PRWEB) , ... June 30, 2015 , ... ... center specializing in affordable addiction care in Florida on June 12th. Holly ... The Fix - a website dedicated to reporting on trending addiction news ...
(Date:6/30/2015)... ... June 30, 2015 , ... Due to today’s housing market, many people cannot afford to “down ... have to make adjustments as to how to carry laundry or groceries from one level ... in the basement or first floor of the home, and the bedrooms are located on ...
Breaking Medicine News(10 mins):Health News:Atlanta Otolaryngologist Dr. Marcelo Antunes Joins Northwest ENT and Allergy Center 2Health News:Atlanta Otolaryngologist Dr. Marcelo Antunes Joins Northwest ENT and Allergy Center 3Health News:NJ Top Doc, Dr. James C. Wittig, has Enhanced his Education Portal on TumorSurgery.org 2Health News:NJ Top Doc, Dr. James C. Wittig, has Enhanced his Education Portal on TumorSurgery.org 3Health News:Micro Com Systems Ltd Now Specializes in Medical Imaging 2Health News:Harbor Village Detox’s Clinical Director Is Quoted as an Addiction Expert by The Fix 2Health News:Harbor Village Detox’s Clinical Director Is Quoted as an Addiction Expert by The Fix 3Health News:Butler Mobility Products announce a Solution to Carry Items from One Floor to the Next with a Dumbwaiter 2
... they,re not getting needed screenings for breast and cervical tumors ... of 32 studies suggests that obese women -- particularly white ... for breast and cervical cancer. , No one knows ... mammograms or Pap smears. And it,s not known why obesity ...
... 2008 WASHINGTON Millions of Americans took the advice to ... becoming infected with the flu. This flu season is ... strains of the virus, making other flu prevention steps even ... and The Clorox Company launched the inFLUenza Resource Center ...
... Alsius Corporation,(Nasdaq: ALUS ), the ... has received approval from regulatory authorities in,China ... management,(IVTM(TM)) systems and catheters in those countries. ... a computer-controlled temperature,regulation system that connects to ...
... you can walk at work instead., GRAND RAPIDS, ... to Work Day. Endorsed by the U.S. Department of ... turn their,commute into an exercise opportunity., (Photo: ... the U.S. Centers for Disease Control,and Prevention, the prevalence ...
... Restatement and Accounting Review ... Continued Trading, MCLEAN, Va., March 24 Sunrise Senior Living,Inc. ... filed its Form,10-K for the year ended December 31, 2006 with ... financial restatement and,accounting review. In addition, the Company announced that by ...
... Singapore to develop future lab-on-chip ... ... of the evaluation trials conducted at the prestigious National,University Hospital of ... commercial availability,of VereFlu(TM), a portable lab-on-chip application for rapid detection of,all ...
Cached Medicine News:Health News:Obese Women Less Likely to Be Tested for Some Cancers 2Health News:Longer flu season and unexpected strains make prevention plan key 2Health News:Alsius Corporation Receives Regulatory Approval in China and Mexico 2Health News:National Walk to Work Day is April 4 2Health News:Sunrise Files 2006 Form 10-K 2Health News:Sunrise Files 2006 Form 10-K 3Health News:Sunrise Files 2006 Form 10-K 4Health News:Sunrise Files 2006 Form 10-K 5Health News:STMicroelectronics and Veredus Laboratories Launch Market's First Lab-on-Chip for Rapid Molecular Flu Detection at Point of Need 2Health News:STMicroelectronics and Veredus Laboratories Launch Market's First Lab-on-Chip for Rapid Molecular Flu Detection at Point of Need 3
(Date:6/30/2015)... -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ) announces the ... StockholdersWhen:Tuesday, June 30 at 5:10 p.m. ET / 2:10 ... onto our website listed above.   If ... a replay of the webcast will be available for ... ABOUT ISIS PHARMACEUTICALS, INC. Isis is exploiting ...
(Date:6/29/2015)... 30, 2015 , Gerresheimer will sell ... and Gerresheimer enter into a 10-year-supply agreement for pharmaceutical ... EUR 196m debt-free Corning and Gerresheimer will ... glass packaging market Gerresheimer,s outlook for the financial ... disposal of the tubing business , In line ...
(Date:6/29/2015)... 29, 2015  Nevro Corp. (NYSE: NVRO ), ... evidence-based solutions for the treatment of chronic pain, today ... Executive Officer of Intersect ENT (NASDAQ: XENT ), ... June 28, 2015. For the last ... Intersect ENT, a company dedicated to improving the quality ...
Breaking Medicine Technology:Webcast Alert: Corporate Presentation at the 2015 Isis Pharmaceuticals Annual Stockholder Meeting 2Webcast Alert: Corporate Presentation at the 2015 Isis Pharmaceuticals Annual Stockholder Meeting 3Gerresheimer Will Sell Tubing Operations to Corning - Both Will Form a Joint Venture to Accelerate Innovations for Pharmaceutical Glass Packaging Market 2Gerresheimer Will Sell Tubing Operations to Corning - Both Will Form a Joint Venture to Accelerate Innovations for Pharmaceutical Glass Packaging Market 3Nevro Appoints Lisa Earnhardt to its Board of Directors 2
... HAIFA, Israel, November 11 Cardio Vascular,Medical ... advanced,cardiovascular surgery technology, today announced the completion of ... . , Cardio Vascular ... innovative,next-generation "steerable guidewire" applicable for all angioplasty (PCTA),procedures. ...
... ACCESS PHARMACEUTICALS, INC. (OTC Bulletin ... commercial launch of MuGard, an FDA approved treatment for oral ... Access intends to commercially launch MuGard in North America ... pertaining to the launch include: , Manufacturing : ...
Cached Medicine Technology:Cardio Vascular Medical Device Launches Corporate Website 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in North America 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in North America 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch in North America 4
Shandon Microscope Slide Cabinet with Drawers...
... data from multiple sources is not ... ResultNet/Plus software allows you to concentrate ... communications network., ,ResultNet/Plus eliminates the complexity ... largescale or multi-site laboratories to host ...
The flexible EXXCEL ePTFE Vascular Access Graft material is designed to offer textile-like handling characteristics-cuts neatly for a clean edge, retains fully open lumen shape, and sutures smoothly....
ACE Control Serum provides the laboratory with vital information on the performance of the ACE chemistry assay....
Medicine Products: